Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00321_DB00615_nanopub.RAqJ83KbKE339nfmrzmF9M2FOD14clVlwJ0w78KF1uwJc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00321_DB00615 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00321_DB00615 label "DDI between Amitriptyline and Rifabutin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, amitriptyline, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amitriptyline if rifabutin is initiated, discontinued or dose changed. [drugbank_resource:DB00321_DB00615]" assertion.
- drugbank_resource:DB00321_DB00615 identifier "drugbank_resource:DB00321_DB00615" assertion.
- drugbank_resource:DB00321_DB00615 title "DDI between Amitriptyline and Rifabutin - The rifamycin, rifabutin, may decrease the effect of the tricyclic antidepressant, amitriptyline, by increasing its metabolism. Monitor for changes in the therapeutic and adverse effects of amitriptyline if rifabutin is initiated, discontinued or dose changed." assertion.
- drugbank:DB00321 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00321_DB00615 assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00321_DB00615 assertion.